Loading...
Loading...
African Journal of Biology and Medical Research
Vol. 7Issue 32024pp. 39–46Published 12 August 2024
DOI 10.52589/AJBMR-Z1G94ONPShare Link
Cite this
Citation unavailable for this article.
Abstract:
Introduction: Urinary tract infections caused by Enterobacteriaceae producing extended- spectrum β-lactamases represent a growing infectious risk, and in many cases may even lead to therapeutic impasses due to their multi-resistance to antibiotics. The aim of this study was to determine the antibiotic susceptibility profile of extended-spectrum betalactamase-secreting uropathogenic enterobacteriaceae isolated at the CHNU de Fann, Dakar . Material and Methods: This was a retrospective study lasting six months (from January 1 to June 30, 2018) concerning all uropathogenic E-BLSE strains isolated at the Bacteriology- Virology laboratory of the CHNU de Fann (Dakar). Results: This study revealed a high prevalence of E-BLSE isolation (41.8%), particularly in outpatients (65.67%). The most represented age group was between 60 and 80 years, with a percentage of 48.11%. E. coli was the most isolated germ (51.49%), followed by Klebsiella pneumoniae (26.87%). A study of the susceptibility profile of EBLSE to other antibiotic molecules revealed high levels of resistance, reaching 100% for sulfamethoxazole trimethoprim and fosfomycin, and 91.3 % for fluoroquinolones. For aminoglycosides, high co-resistance was observed with gentamicin (85.7%), while it was low with amikacin (3.84%). Our results also showed 100% sensitivity to imipenem. Conslusion: The emergence of extended-spectrum ß-lactamase-producing urinary tract infections is a major public health problem. Faced with this alarming and worrying situation, and in order to limit the emergence of healthcare-associated infections, it has become imperative to improve hospital hygiene. Key words: Urinary tract infections, enterobacteria, ESBL, CHNU de Fann.
Disclaimer/Publisher’s Note
The statements, opinions and data contained in this publication are solely those of the author(s) and contributor(s) and not of AB Journals or its editors. AB Journals remains neutral and accepts no responsibility for any injury or damage resulting from ideas, methods, instructions or products referred to in the content.
Copyrights